APA Alıntı

Mahajan, R. (2009). Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes. Medknow Publications.

Chicago Stili Alıntı

Mahajan, Rajiv. Bromocriptine Mesylate: FDA-approved Novel Treatment for Type-2 Diabetes. Medknow Publications, 2009.

MLA Alıntı

Mahajan, Rajiv. Bromocriptine Mesylate: FDA-approved Novel Treatment for Type-2 Diabetes. Medknow Publications, 2009.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..